The CEO said last month that the drugmaker had cut costs, revamped its sales operation, and made other big fixes.

Activist investor Starboard Value has taken a stake in Becton Dickinson and is pushing the $72bn medical technology company to sell its life sciences division, according to people familiar with the ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $150 billion and annual revenue exceeding $59 billion, announced today that its Phase 3 BREAKWATER study ...

Key highlights: <li /> FGS tops the global M&A rankings, while Prosek surges into second place in deal count; <li /> In Europe, Italy ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a Standalone Total ...

Bonus Sep 11, 1995 Oct 04, 1995 Sep 08, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights Dec 18, 1992 Jan 15, 1993 Sep 30, 1993 Rights ratio: 2 share for every 5 held at a price of Rs 35.0 ...